| Efficacy of antibodies and antiviral drugs against Covid-19 Omicron variant E Takashita, N Kinoshita, S Yamayoshi, Y Sakai-Tagawa, S Fujisaki, M Ito, ... New England Journal of Medicine 386 (10), 995-998, 2022 | 365 | 2022 |
| Comparison of rapid antigen tests for COVID-19 S Yamayoshi, Y Sakai-Tagawa, M Koga, O Akasaka, I Nakachi, H Koh, ... Viruses 12 (12), 1420, 2020 | 232 | 2020 |
| Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA. 2 R Uraki, M Kiso, S Iida, M Imai, E Takashita, M Kuroda, PJ Halfmann, ... Nature 607 (7917), 119-127, 2022 | 223 | 2022 |
| Antibody titers against SARS-CoV-2 decline, but do not disappear for several months S Yamayoshi, A Yasuhara, M Ito, O Akasaka, M Nakamura, I Nakachi, ... EClinicalMedicine 32, 2021 | 150 | 2021 |
| Humoral immune evasion of the omicron subvariants BQ. 1.1 and XBB R Uraki, M Ito, Y Furusawa, S Yamayoshi, K Iwatsuki-Horimoto, E Adachi, ... The Lancet Infectious Diseases 23 (1), 30-32, 2023 | 128 | 2023 |
| Characterization of a new SARS-CoV-2 variant that emerged in Brazil M Imai, PJ Halfmann, S Yamayoshi, K Iwatsuki-Horimoto, S Chiba, ... Proceedings of the National Academy of Sciences 118 (27), e2106535118, 2021 | 76 | 2021 |
| Longitudinal antibody repertoire in “mild” versus “severe” COVID-19 patients reveals immune markers associated with disease severity and resolution S Ravichandran, Y Lee, G Grubbs, EM Coyle, L Klenow, O Akasaka, ... Science advances 7 (10), eabf2467, 2021 | 74 | 2021 |
| Gargle lavage as a safe and sensitive alternative to swab samples to diagnose COVID-19: a case report in Japan M Saito, E Adachi, S Yamayoshi, M Koga, K Iwatsuki-Horimoto, ... Clinical Infectious Diseases 71 (15), 893-894, 2020 | 67 | 2020 |
| Deleterious effects of malaria in pregnancy on the developing fetus: a review on prevention and treatment with antimalarial drugs M Saito, V Briand, AM Min, R McGready The lancet child & adolescent health 4 (10), 761-774, 2020 | 49 | 2020 |
| Indications and classes of outpatient antibiotic prescriptions in Japan: A descriptive study using the national database of electronic health insurance claims, 2012–2015 H Hashimoto, M Saito, J Sato, K Goda, N Mitsutake, M Kitsuregawa, ... International Journal of Infectious Diseases 91, 1-8, 2020 | 47 | 2020 |
| Correlation analysis between gut microbiota alterations and the cytokine response in patients with coronavirus disease during hospitalization T Mizutani, A Ishizaka, M Koga, K Ikeuchi, M Saito, E Adachi, ... Microbiology spectrum 10 (2), e01689-21, 2022 | 44 | 2022 |
| Efficacy and tolerability of artemisinin-based and quinine-based treatments for uncomplicated falciparum malaria in pregnancy: a systematic review and individual patient data … M Saito, R Mansoor, K Kennon, AR Anvikar, EA Ashley, D Chandramohan, ... The Lancet Infectious Diseases 20 (8), 943-952, 2020 | 42 | 2020 |
| Relative bradycardia in patients with mild-to-moderate coronavirus disease, Japan K Ikeuchi, M Saito, S Yamamoto, H Nagai, E Adachi Emerging infectious diseases 26 (10), 2504, 2020 | 41 | 2020 |
| Association of HLA‐DRB1*09:01 with severe COVID‐19 A Anzurez, I Naka, S Miki, K Nakayama‐Hosoya, M Isshiki, Y Watanabe, ... Hla 98 (1), 37-42, 2021 | 38 | 2021 |
| Antimalarial drugs for treating and preventing malaria in pregnant and lactating women M Saito, ME Gilder, R McGready, F Nosten Expert Opinion on Drug Safety 17 (11), 1129-1144, 2018 | 38 | 2018 |
| Comparison of patient characteristics and in-hospital mortality between patients with COVID-19 in 2020 and those with influenza in 2017–2020: a multicenter, retrospective … Y Taniguchi, T Kuno, J Komiyama, M Adomi, T Suzuki, T Abe, M Ishimaru, ... The Lancet Regional Health–Western Pacific 20, 2022 | 36 | 2022 |
| Association of coagulopathy with liver dysfunction in patients with COVID‐19 T Tsutsumi, M Saito, H Nagai, S Yamamoto, K Ikeuchi, LA Lim, E Adachi, ... Hepatology Research 51 (2), 227-232, 2021 | 33 | 2021 |
| In vitro efficacy of antiviral agents against Omicron subvariant BA. 4.6 E Takashita, S Yamayoshi, P Halfmann, N Wilson, H Ries, A Richardson, ... New England Journal of Medicine 387 (22), 2094-2097, 2022 | 26 | 2022 |
| Characterization of the SARS-CoV-2 B. 1.621 (Mu) variant PJ Halfmann, M Kuroda, T Armbrust, J Theiler, A Balaram, GK Moreno, ... Science translational medicine 14 (657), eabm4908, 2022 | 24 | 2022 |
| Antibody response to SARS-CoV-2 in people living with HIV S Yamamoto, M Saito, E Nagai, K Toriuchi, H Nagai, H Yotsuyanagi, ... Journal of Microbiology, Immunology, and Infection 54 (1), 144, 2021 | 24 | 2021 |
